Cargando…
Rekombinante, vollständig humane Antikörper zur Behandlung akuter COVID-19
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318721/ https://www.ncbi.nlm.nih.gov/pubmed/32834543 http://dx.doi.org/10.1007/s12268-020-1404-4 |
| _version_ | 1783550918387564544 |
|---|---|
| author | Dübel, Stefan Hust, Michael Frenzel, André Schirrmann, Thomas |
| author_facet | Dübel, Stefan Hust, Michael Frenzel, André Schirrmann, Thomas |
| author_sort | Dübel, Stefan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7318721 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73187212020-06-29 Rekombinante, vollständig humane Antikörper zur Behandlung akuter COVID-19 Dübel, Stefan Hust, Michael Frenzel, André Schirrmann, Thomas Biospektrum (Heidelb) Karriere, Köpfe & Konzepte Springer Berlin Heidelberg 2020-06-26 2020 /pmc/articles/PMC7318721/ /pubmed/32834543 http://dx.doi.org/10.1007/s12268-020-1404-4 Text en © Springer-Verlag GmbH 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Karriere, Köpfe & Konzepte Dübel, Stefan Hust, Michael Frenzel, André Schirrmann, Thomas Rekombinante, vollständig humane Antikörper zur Behandlung akuter COVID-19 |
| title | Rekombinante, vollständig humane Antikörper zur Behandlung akuter COVID-19 |
| title_full | Rekombinante, vollständig humane Antikörper zur Behandlung akuter COVID-19 |
| title_fullStr | Rekombinante, vollständig humane Antikörper zur Behandlung akuter COVID-19 |
| title_full_unstemmed | Rekombinante, vollständig humane Antikörper zur Behandlung akuter COVID-19 |
| title_short | Rekombinante, vollständig humane Antikörper zur Behandlung akuter COVID-19 |
| title_sort | rekombinante, vollständig humane antikörper zur behandlung akuter covid-19 |
| topic | Karriere, Köpfe & Konzepte |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318721/ https://www.ncbi.nlm.nih.gov/pubmed/32834543 http://dx.doi.org/10.1007/s12268-020-1404-4 |
| work_keys_str_mv | AT dubelstefan rekombinantevollstandighumaneantikorperzurbehandlungakutercovid19 AT hustmichael rekombinantevollstandighumaneantikorperzurbehandlungakutercovid19 AT frenzelandre rekombinantevollstandighumaneantikorperzurbehandlungakutercovid19 AT schirrmannthomas rekombinantevollstandighumaneantikorperzurbehandlungakutercovid19 |